By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Uncapped with Jack AltmanConcentrating in Winners | Vince Hankes, Partner at Thrive Capital | Ep. 27
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Thrive Capital’s playbook for concentrated, conviction-led venture investing at scale
- Thrive grew from a small, New York-based outsider fund into a platform capable of writing billion-dollar checks, while trying to preserve its contrarian, high-conviction culture.
- Hankes argues that concentration requires “dogmatic conviction,” built through long wind-up periods of relationship-building, deep qualitative diligence, and then quantitative validation.
- He details Thrive’s barbell approach (early + platform/growth) and explains why mid-stage “large check venture” can be the most perilous due to competition and capital-loss risk.
- The conversation also covers Thrive’s Carvana trade, conflict management in a concentrated portfolio, and where AI value accrues—plus why life sciences and robotics may be the biggest long-term AI opportunities.
IDEAS WORTH REMEMBERING
5 ideasConcentration demands near-absolute conviction—and time is the price.
Thrive’s biggest checks come after long relationship “wind-ups” (e.g., ~10 years from first Stripe investment to a $2B check; ~18 months getting to know Isomorphic). This duration is treated as a core input to conviction, not a luxury.
Start qualitative, then use numbers to confirm—not to inspire.
Hankes says leading with metrics can create fragile confidence when growth decelerates. Thrive forms a qualitative hypothesis around people/product/customers first, then uses data to validate it—so short-term misses don’t automatically break the thesis.
Thrive’s growth funds are intentionally designed to be small-N portfolios.
He describes an “ideal growth fund” as ~10 companies, aiming to map fund construction to the power law. The firm keeps investor headcount low (about eight investors) to avoid deal proliferation and dilution of conviction.
The best odds may be backing $10B companies on the path to $100B+, not picking unicorns early.
Hankes cites a growing number of $100B+ outcomes and argues it can be easier to identify “generational platform” trajectories at scale than to select a breakout from thousands of earlier-stage contenders.
Mid-stage ‘large-check venture’ is a danger zone when $100M checks meet uncertain PMF.
He’s skeptical of the heavily funded $500M–$2B segment where many companies are priced like they have PMF even when it’s unproven. At $100M check sizes, “zeros” are hard to survive, making capital-loss risk central.
WORDS WORTH SAVING
5 quotesWhen you write a billion dollars into a company, you have to have conviction… almost dogmatic conviction.
— Vince Hankes
Our philosophy is we start with the qualitative… and then the hypothesis has to be confirmed by the quantitative.
— Vince Hankes
It’s a lot easier to predict the long term than it is the short term.
— Vince Hankes
The vast majority of dollars of enterprise value that get created are in the second or third decade of a company.
— Vince Hankes
Today… 120% of the profit in AI is from NVIDIA.
— Vince Hankes
High quality AI-generated summary created from speaker-labeled transcript.
